T. Rowe Price Investment Management
SANA icon

T. Rowe Price Investment Management’s Sana Biotechnology SANA Stock Holding History

T. Rowe Price Investment Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-374,169
Closed -$1.56M – 669
2024
Q3 		$1.56M Sell
374,169
-1,184,060
-76% -$6.22M ﹤0.01% 592
2024
Q2 		$8.51M Sell
1,558,229
-3,243,618
-68% -$25.8M 0.01% 550
2024
Q1 		$48M Buy
+4,801,847
New +$36M 0.03% 402

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management's SANA Position: Q4 2024 in Review

T. Rowe Price Investment Management sold out of Sana Biotechnology (SANA) in Q4 2024, closing a stake of 374,169 shares — an estimated $1.56M sold.

T. Rowe Price Investment Management first reported a position in SANA in Q1 2024 and held it in 3 quarters. The position peaked at $48M in Q1 2024. 164 funds tracked by Wall St. Rank hold SANA as of Q4 2024.

  • T. Rowe Price Investment Management reported no remaining Sana Biotechnology position as of Q4 2024 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 374,169 Sana Biotechnology shares in Q4 2024, an estimated $1.56M.
  • T. Rowe Price Investment Management first reported a position in Sana Biotechnology in Q1 2024 and held it in 3 quarters.
  • T. Rowe Price Investment Management's Sana Biotechnology position peaked at $48M in Q1 2024.
  • 164 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2024.

Based on T. Rowe Price Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.